![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
The fluocinolone acetonide (Retisert™) implant is an approved therapy for chronic, posterior, non-infectious uveitis. Continued episodes of inflammation can occur in patients after device implantation and suspected Retisert™ malfunction has been previously reported. We report a case of a patient who continued to have inflammation after Retisert™ implantation, which subsided after device exchange with a normally functioning explant after detailed manufacturer analysis.
ACKNOWLEDGMENT
Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.